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Background: COPD is a progressive lung disease characterized by emphysema
and enhanced bronchoconstriction. Current treatments focused on bronchodilation
can delay disease progression to some extent, but recovery or normalization of loss
of lung function is impossible. Therefore, novel therapeutic targets are needed. The
importance of the parenchyma in airway narrowing is increasingly recognized. In COPD,
the parenchyma and extracellular matrix are altered, possibly affecting airway mechanics
and enhancing bronchoconstriction. Our aim was to set up a comprehensive ex vivo
Precision Cut Lung Slice (PCLS) model with a pathophysiology resembling that of COPD
and integrate multiple readouts in order to study the relationship between parenchyma,
airway functionality, and lung repair processes.
Methods: Lungs of C57Bl/6J mice were sliced and treated ex vivo with elastase
(2.5 µg/ml) or H2O2 (200 µM) for 16 h. Following treatment, parenchymal structure,
airway narrowing, and gene expression levels of alveolar Type I and II cell repair were
assessed.
Results: Following elastase, but not H2O2 treatment, slices showed a significant
increase in mean linear intercept (Lmi), reflective of emphysema. Only elastase-treated
slices showed disorganization of elastin and collagen fibers. In addition, elastase
treatment lowered both alveolar Type I and II marker expression, whereas H2O2
stimulation lowered alveolar Type I marker expression only. Furthermore, elastase-treated
slices showed enhanced methacholine-induced airway narrowing as reflected by
increased pEC50 (5.87 at basal vs. 6.50 after elastase treatment) and Emax values (47.96
vs. 67.30%), and impaired chloroquine-induced airway opening. The increase in pEC50
correlated with an increase in mean Lmi.
Conclusion: Using this model, we show that structural disruption of elastin fibers leads
to impaired alveolar repair, disruption of the parenchymal compartment, and altered
airway biomechanics, enhancing airway contraction. This finding may have implications
for COPD, as the amount of elastin fiber and parenchymal tissue disruption is associated
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with disease severity. Therefore, we suggest that PCLS can be used to model certain
aspects of COPD pathophysiology and that the parenchymal tissue damage observed in
COPD contributes to lung function decline by disrupting airway biomechanics. Targeting
the parenchymal compartment may therefore be a promising therapeutic target in the
treatment of COPD.
Keywords: airway mechanics, extracellular matrix, chronic obstructive pulmonary disease
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is a disabling
disease and life-threatening. COPD is characterized by an
abnormal inflammatory response of the lungs to noxious
particles or gases, and this abnormal response is associated with
progressive airflow limitation. Long-term exposure to cigarette
smoke is a major risk factor for the development of COPD
(Pauwels et al., 2001; Rabe et al., 2007). Major pathophysiological
characteristics that enhance the decline of lung function and
contribute to airway obstruction are inflammation, airway wall
remodeling, bronchoconstriction, mucus hypersecretion, high
levels of oxidative stress, and an abnormal increase in air
spaces (emphysema; Barnes et al., 2003). Worldwide, COPD
is the fourth leading cause of death. By 2020 it expected to
be the third leading cause of death (COPD, 2016). Available
treatments can delay disease progression to some extent, but
recovery or normalization of loss of lung function is not
possible. Bronchodilators are currently the golden standard
for COPD treatment as they reduce bronchoconstriction and
airflow obstruction by inducing airway smooth muscle (ASM)
relaxation. However, even the most recent combination therapies
of long-acting β2 agonists and long-acting anticholinergics have
a limited effect on improving lung function since they improve
trough FEV1 by a range of ∼150–200 mL only (Buhl et al., 2015;
Vogelmeier et al., 2013). Although this improvement is clinically
significant, clearly other factors than the ASM contribute to the
decline of lung function in COPD.
The parenchyma around the airways is known to have an
important role in airway narrowing (Bidan et al., 2015). The
alveolar tissue is defined by the parenchyma and it consists of a
large proportion of the extracellularmatrix (ECM) and interstitial
cells. The parenchymal compartment is connected to the airways
via parenchymal tethers. These tethers transmit forces to the
airways, linking chest movements during inspiration to airway
opening (Suki and Bates, 2008, 2011; Lauzon et al., 2012). The
parenchymal mechanical and structural properties therefore have
a major impact on airway mechanics. In healthy lung tissue,
the parenchyma maintains the elastic recoil which counteracts
airway narrowing. Parenchymal tethers on the outside of an
airway transmit trans-pulmonary pressure to the airway wall,
thereby opposing the shortening of the ASM (Ma and Bates,
2014). As a result, parenchymal tethering supports the relaxant
effect of deep inspiration and reduces bronchoconstriction (An
et al., 2007). Changes of parenchymal properties are therefore
likely to affect airway narrowing (Bidan et al., 2015). In COPD,
the parenchyma and ECM are altered, leading to a loss of elastic
recoil (Eurlings et al., 2014; Bidan et al., 2015). These alterations,
caused by the presence of elastolytic enzymes and oxidative
stress, lead to damage of the parenchyma, and ECM (Chung
and Adcock, 2008; Kirkham and Barnes, 2013). Therefore, the
increased levels elastolytic enzymes and oxidative likely affect
airway mechanics in COPD and enhance bronchoconstriction.
In order to have a better understanding of enhanced airway
narrowing in COPD, it is therefore important to investigate the
role of the parenchymal compartment. This role is especially
interesting in mild or moderate COPD, as changes in the
parenchymal compartment are not very profound yet in this
stage, and possibly still reversible. In order to develop a
therapeutic approach to restore parenchymal properties and
possibly reduce airway narrowing in COPD, a model in which
the underlying pathological processes can be investigated is
needed. A previous study by Khan et al. demonstrated that
ex vivo elastase treatment of mouse lung slices enhanced the
velocity of acetylcholine-induced contraction, while the velocity
of relaxation was significantly suppressed (Khan et al., 2007).
These results indicate that parenchymal damage may indeed
enhance airway narrowing.
In the present work, we aimed to expand this model
by studying the impact of low level elastase and oxidative
stress exposure on airway narrowing and relaxation in relation
to parenchymal and ECM structure, and (in)activation of
alveolar epithelial repair. We used an ex vivo Precision Cut
Lung Slice (PCLS) model to mimic these aspects of COPD
pathophysiology. PCLS, unlike isolated airway rings, have the
advantage that the attachments between the small airways and
the surrounding parenchyma remain intact during preparation.
Therefore, PCLS are suitable to study the relationship between
parenchymal structure and airway function. In addition, the
benefit of such an ex vivo model is that it enables all the
experimental conditions to be performed within the same
animal and thus helps limit the number of animals needed
and their discomfort as compared to an in vivo approach. We
hypothesized that ex vivo treatment of lung slices with elastase
or H2O2 would damage the parenchyma and therefore enhance
bronchoconstriction.
MATERIALS AND METHODS
Antibodies and Reagents
Methacholine (MCh) was obtained from ICN Biomedicals
(Zoetermeer, the Netherlands). Alexa Fluor R© 488 Phalloidin
was purchased from Life technologies. Mouse anti-E-cadherin
was obtained from BD Biosciences (Bedford, MA, USA), and
Cy3-conjugated secondary antibody was purchased from Jackson
ImmunoResearch (West Grove PA, USA). Elastase from porcine
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pancreas Type IV and chloroquine were received from Sigma-
Aldrich (Zwijndrecht, The Netherlands).
Animals
C57bl/6 male and female mice (weight 23–41 g; age 12–40
weeks) were obtained from Innoser (Lelystad, The Netherlands).
Animals were maintained on mouse chow and tap water ad
libitum in a humidity- and temperature-controlled room at 24◦C
with a 12 h light/dark cycle. All experiments were performed
according to the national guidelines and upon approval of the
experimental procedures by the local Animal Care and Use
committee of Groningen University, DEC number 6815A.
Precision-Cut Lung Slices
Precision-cut lung slices were prepared as described previously
(Oenema et al., 2013). Animals were euthanized by subcutaneous
injection with ketamine (40 mg/kg, Alfasan, Woerden, The
Netherlands) and dexdomitor (0.5 mg/kg, Orion Pharma,
Mechelen, Belgium). Following euthanization, the trachea was
cannulated, and the animal was ex-sanguinated via the aorta
abdominalis. Subsequently, the lungs were inflated through the
cannula with a low melting-point agarose solution (1.5% final
concentration (Gerbu Biotechnik GmbH,Wieblingen, Germany)
in CaCl2 (0.9 mM), MgSO4 (0.4 mM), KCl (2.7 mM), NaCl
(58.2 mM), NaH2PO4 (0.6 mM), glucose (8.4 mM), NaHCO3 (13
mM), HEPES (12.6 mM), sodium pyruvate (0.5 mM), glutamine
(1 mM), MEM-amino acids mixture (1:50), and MEM-vitamins
mixture (1:100), pH = 7.2). Following inflation, lungs were
placed on ice for 15 min, so that the agarose could solidify for
slicing. Next, the lungs were separated into individual lobes.
These lobes were used to prepare tissue cores, after which the
lobes were sliced at a thickness of 250 µm, which was the same
for all further experimental procedures. Slicing was performed
in medium composed of CaCl2 (1.8 mM), MgSO4 (0.8 mM),
KCl (5.4 mM), NaCl (116.4 mM), NaH2PO4 (1.2 mM), glucose
(16.7 mM), NaHCO3 (26.1 mM), HEPES (25.2 mM), pH = 7.2,
using a tissue slicer (CompresstomeTM VF- 300 microtome,
Precisionary Instruments, San Jose CA, USA). Lung slices were
incubated in a humid atmosphere under 5% CO2/95% air at
37◦C. Every 30min slices were washed (four times in total). PCLS
were incubated in DMEM supplemented with sodium pyruvate
(1 mM), MEM non-essential amino acid mixture (1:100; Gibco R©
by Life Technologies), gentamycin (45 µg/ml; Gibco R© by Life
Technologies), penicillin (100 U/ml), streptomycin (100 µg/ml),
and amphotericin B (1.5 µg/ml; Gibco R© by Life Technologies).
Slices were cultured at 37◦C in a humidified atmosphere under
5% CO2/95% air in 12-well tissue culture plates, using three
to four slices per well. Matched slices from the same mouse
were treated with elastase (0–2.5 µg/ml, Sigma Aldrich) or H2O2
(0–800 µM, Merck) for 16 h. Following treatment, slices were
washed twice with medium and incubated for another 24 h after
which the slices were collected. Previous work from our lab
(unpublished) demonstrated that mouse lung slice viability is
preserved after 72 h of culturing, as mitochondrial activity did
not change. This indicates that the lung slice is viable for at least
3 days. Our experiments were all performed within 56 h after
sacrifice.
mRNA Isolation and Real-Time PCR
Total RNA was extracted from PCLS by using the Maxwell
16 instrument and corresponding Maxwell 16 LEV simply
RNA tissue kit (Promega, Madison, USA) for automated
purification according to manufacturer’s instructions. The
Reverse Transcription System (Promega, Madison, USA) was
used to reverse transcribe equal amounts of total RNA (1 µg).
cDNA was diluted four times after which 1 µl was subjected to
real-time PCR This was done with the Illumina Eco Personal
QPCR System (Westburg, Leusden, the Netherlands) using
FastStart Universal SYBR Green Master (Rox) from Roche
Applied Science (Mannheim, Germany). Real-time PCR was
performed with denaturation at 95◦C for 30 s, annealing at 59◦C
for 30 s and extension at 72◦C for 30 s for 40 cycles followed by
5 min at 72◦C. The amount of target gene was normalized to
the endogenous reference genes β-2 microglobulin (B2M) and
ribosomal protein L13A (RPL13). Genetic markers in treated or
untreated slices from the same mouse were incubated in parallel
for a similar time interval and were compared and expressed
as percent basal. Analysis of RT-PCR data was performed using
LinRegPCR analysis software (Ruijter et al., 2009, 2013). Primer
sets used to analyze gene expression are shown in Table 1.
Tissue Staining and Confocal Laser
Scanning Microscopy to Visualize
Parenchymal Cells
To visualize the parenchyma of the PCLS, slices were stained for
F-actin and E-cadherin. PCLS were fixed for 15 min at 4◦C in
cytoskeletal buffer (CB) (10 mM Tris base, 150 mM NaCl, 5 mM
EGTA, 5 mM MgCl2, and 5 mM glucose at pH 6.1) containing
3% paraformaldehyde (PFA). PCLS were then permeabilized by
incubation for 5 min at 4◦C in CB containing 3% PFA and
0.3% Triton X-100. Subsequently, PCLS were washed twice with
4◦C CB. For immunofluorescence microscopy, fixed PCLS were
first blocked for 1 h at room temperature in Cyto-TBS buffer
(200 mM Tris base, 154 mM NaCl, 20 mM EGTA and 20 mM
MgCl2at pH 7.2) containing 1% bovine serum albumin and
TABLE 1 | Primers used for RT-PCR analysis.
mRNA Primer
Mouse B2m Fwd 5′-ACCGTCTACTGGGATCGAGA-3′
Rev 5′-TGCTATTTCTTTCTGCGTGCAT-3′
Mouse Rpl13a Fwd 5′-AGAAGCAGATCTTGAGGTTACGG-3′
Rev 5′-GTTCACACCAGGAGTCCGTT-3′
Mouse Aqp5 Fwd 5′-CTTGTGGGGATCTACTTCACCG-3′
Rev 5′-AAGTAGAGGATTGCAGCCAGG-3′
Mouse T1α Fwd 5′-TCACCCCAATAGAGATGGCTTG-3′
Rev 5′-GGGCAAGTTGGAAGCTCTCTT-3′
Mouse Rage Fwd 5′-CACAGGCTCTGTGGGTGAG-3′
Rev 5′-TTCAGCTCTGCACGTTCCTC-3′
Mouse Con43 Fwd 5′-TCCTTTTCCTTTGACTTCAGCCTC-3′
Rev 5′-TCTGAAAATGAAGAGCACCGACA-3′
Mouse Sftpc Fwd 5′-GGAGCACCGGAAACTCAGAA-3′
Rev 5′-GGAGCCGCTGGTAGTCATAC-3′
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2% normal donkey serum. PCLS were incubated with primary
antibody (E-Cadherin, 1:100, BD biosciences) overnight at 4◦C in
Cyto-TBS containing 0.1% Tween 20 (Cyto-TBST). The next day,
PCLS were incubated with Alexa Fluor R© 488 Phalloidin (1:100,
Life technologies) and Cy3-conjugated secondary antibody (1:50,
Jackson ImmunoResearch) for 2 h at room temperature in Cyto-
TBST containing 1% BSA. Between incubation steps slices were
washed with Cyto-TBST. Following staining, coverslips were
mounted using ProLong Gold antifade reagent (Invitrogen).
Fluorescence was determined with a confocal laser scanning
microscope (CLSM) equipped with true confocal scanner (TCS;
SP8 Leica, Heidelberg, Germany), using a 200x lens. To avoid
bleed through, sequential scans were performed. AlexaFluor488
was excited using the 488 nm blue laser line, and CyTM3 was
excited using the 552 nm green laser line. All images were
recorded in the linear range, at an image resolution of 1024 ×
1024 pixels and with a pinhole size of 1 Airy unit, while avoiding
local saturation. The images presented here show a single z-scan.
ImageJ 1.48d was used to further process images (Schindelin
et al., 2012).
2-Photon Imaging and Autofluorescence to
Visualize the ECM
2-Photon and multiphoton excitation fluorescence (MPEF)
imaging were used to visualize collagen and elastin polymers,
respectively, as described previously (Abraham and Hogg,
2010). Following stimulation with either elastase or H2O2,
PCLS were washed twice with PBS and directly mounted on
coverslips. Under excitation at 820 nm, the collagen bundles
naturally emitted a second harmonic generation signal collected
around 410 nm. Elastin was visualized by using its endogenous
fluorescence. Images from elastin were generated by using
infrared laser (excitation wavelength 880 nm). The measured
broadband emission spectrum ranged from 455 to 650 nm with a
peak at∼500 nm.
Mean Linear Intercept (Lmi)
To assess emphysema in the PCLS, the mean linear intercept
(Lmi) was determined as a measure of mean distance of free
airspace, as described previously (van der Strate et al., 2006).
Following staining with Alexa Fluor R© 488 Phalloidin (1:100, Life
technologies) the alveolar structure was visualized by confocal
microscopy (magnification 200x). Two fields per animal were
used to determine Lmi. As the lungs were filled with agarose
under a varying pressure, Lmi differs between animals due to
the experimental protocol. However, in this PCLS model animals
served as their own control as all experimental conditions were
performed within the same animal. Hence, the treatment effect
on Lmi was normalized (percent basal) within the animal,
and these normalized values were compared between animals.
Therefore, the variance in Lmi caused by the experimental
protocol was excluded.
Airway Narrowing Studies
Airway narrowing studies were performed within the same
mouse on untreated slices and on slices treated with elastase
(2.5 µg/ml) or H2O2 (200 µM). Dose response curves for
MCh (10−9–10−3M) were recorded, after which the airways
were dilated using the bitter taste receptor agonist chloroquine
(10−3M, Sigma-Aldrich). A nylon mesh and metal washer were
used to fixate the lung slice, as described previously (Rosner et al.,
2014). Lung slice images were captured in time-lapse (1 frame
per 2 s) using a microscope (Eclipse, TS100; Nikon). To quantify
airway luminal area, image acquisition software (NIS-elements;
Nikon) was used. Luminal area is expressed as percent basal.
Data Analysis (Statistics)
Values reported for all data are represented as mean ± SEM.
The statistical significance of differences between means was
determined on log transformed data by Student’s t-test or
one-way ANOVA, followed by a Bonferroni correction where
appropriate. Log-transformation was performed prior to the
statistic calculations when data were normalized to percentage of
baseline. While such normalization can be useful to demonstrate
an effect of treatment relative to control, it distorts Gaussian
distribution of data. Log transformation of is then necessary
to re-obtain Gaussian distribution and parametric testing is in
such cases allowed. Differences were considered to be statistically
significant when p < 0.05.
RESULTS
Elastase, but Not H2O2 Treatment Disrupts
the Parenchyma
Our first aim was to create tissue damage in the PCLS resembling
the tissue damage seen in COPD. Therefore, we first investigated
whether elastase and H2O2 were able to induce parenchymal
tissue damage. PCLS were treated with increasing concentrations
of elastase (0, 0.16, 0.31, 0.63, 1.25, and 2.5 µg/ml) and H2O2
(0, 50, 100, 200, 400, 800 µM) and ECM and alveolar epithelial
markers were assessed. Based on these initial results (data not
shown due to a low n), 2.5 µg/ml elastase and 200 µM of H2O2
were chosen for all the following experiments. Following elastase
treatment gene expression levels of Sftpc decreased (moderately),
with little difference between the dosage used. The effect of
elastase treatment on ECM marker gene expression levels was
rather variable. Confocal images of the parenchymal structure
demonstrated that only the highest dose of 2.5 µg/ml elastase
enhanced Lmi. Based on these observations, we chose to work
with 2.5 µg/ml elastase in further experiments. H2O2 treatment
induced small increases or decreases of Sftpc and ECM markers,
depending on the concentration. The highest decrease in Sftpc
and ECM markers was observed at the highest dose of 800 µM.
However, at this dose we observed visually that the PCLS were
very fragile and too disintegrated to use. Therefore, the effect
of H2O2 800 µM treatment on Sftpc and ECM gene expression
levels is more likely to reflect general cell death than a specific
effect of H2O2. Based on these findings we chose to work with 200
µM H2O2, as these slices showed only small decreases in Sftpc
and ECM gene expression levels and were still intact. To assess
emphysema in the PCLS, the Lmi was determined as a measure of
mean distance of free airspace. Following elastase, but not H2O2
stimulation, the mean free distance in air spaces was increased
as compared to basal (set at 100%) as reflected by an enhanced
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Lmi [elastase 120.6% (p = 0.04) and H2O2 111.9% (p = 0.76);
Figures 1A–C]. 2-Photon and MPEF imaging of elastase-treated
slices showed a disrupted elastin and collagen fiber organization,
whereas H2O2-treated slices did not show this effect. Under
basal conditions, both elastin and collagen fibers were clearly
present. The elastin fibers had a straight appearance whereas the
collagen fibers were coiled (Figure 2). Under elastase, but not
under H2O2, conditions, the elastin fibers were absent whereas
the collagen fibers became more stretched (Figure 2).
Elastase and Treatment Decreases Gene
Expression Levels of Alveolar Type I and II
Cell Markers
To further investigate the parenchymal damage induced by
elastase and H2O2, markers of alveolar epithelial Type I and II
cells were assessed: T1α and Aqp5 (specific for alveolar Type I
cells), Con43 and Rage (both alveolar Type I cell associated), and
Sftpc (specific for alveolar Type II cells; McElroy and Kasper,
2004; Smirnova et al., 2016). In our model, the structural damage
caused by elastase was associated with a specific decrease in
expression of alveolar type I and II markers. Following elastase
(2.5 µg/ml) stimulation for 16 h, gene expression levels of
Aqp5, Rage, and Sftpc, but not Con43 or T1α, were decreased
(Figure 3A). H2O2treatment (200 µM) for 16 h decreased gene
expression levels of Rage, Con43, and T1α, but not of Aqp5 or
Sftpc (Figure 3B). Taken together, this shows that in addition
to disrupting the parenchymal matrix, elastase, but not H2O2,
decreases gene expression levels of alveolar Type II markers.
Elastase, but not H2O2 Treatment
Enhances Airway Narrowing
Our second aim was to study the relationship between the
parenchyma and airway functionality. Therefore, we investigated
the effect of elastase and H2O2 treatment on MCh-induced
airway narrowing. Elastase enhanced MCh-induced airway
narrowing as shown by a significant increase in pEC50 (5.87
vs. 6.50, p < 0.001), and increased Emax (47.96 vs. 67.30%
contraction), although not significantly (Figure 4A). H2O2
did not change pEC50 (5.87 vs. 6.08), nor Emax (47.96 vs.
58.82% contraction (Figure 4B). Interestingly, when values for
all conditions were combined, we found pEC50 correlated with
Lmi, whereas Emax did not (Figures 5A,B). Subsequent to
maximal methacholine-induced airway narrowing, we applied
chloroquine as a relaxant to induce airway re-opening.
Chloroquine was chosen for this purpose as β2-agonists failed to
do so in these murine peripheral airways (not shown). Airways
FIGURE 1 | Elastase, but not H2O2 treatment increases Lmi. PCLS were exposed to elastase (2.5 µg/ml, n = 6) or H2O2 (200 µM, n = 5) for 16 h. After
stimulation, slices were washed twice with medium and incubated for 24 h in medium. (A) Following incubation, slices were stained for F-actin filaments (green) and
E-cadherin (red) and Lmi was assessed as % basal. (B,C) Lmi following treatments shown in µm. The statistical significance of differences between means was
determined on log transformed data by Student’s t-test (A) or by Student’s t-test (B,C). Data represent mean ± SEM, *p < 0.05 compared to basal control.
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FIGURE 2 | Elastase, but not H2O2 treatment disrupts the structural organization of elastin and collagen. PCLS were exposed to elastase (2.5 µg/ml) or
H2O2 (200 µM) for 16 h. After stimulation, slices were washed twice with medium and incubated for 24 h in medium. 2-Photon and multiphoton excitation
fluorescence (MPEF) imaging were used to visualize collagen and elastin polymers. Following elastase, but not H2O2, elastin and collagen showed a disrupted fiber
organization.
in slices treated with elastase did not fully return to their original
size after chloroquine-induced relaxation, in contrast to slices
treated with H2O2 (Figure 6). Taken together, these findings
indicate that elastase, but not H2O2 treatment enhances airway
narrowing in PCLS and limits airway re-opening to its original
size.
DISCUSSION
COPD is characterized by progressive airflow limitation, and it is
increasingly recognized that the parenchymal compartment may
play an important role in airway narrowing. Our aim was to set
up an ex vivo PCLS model mimicking structural abnormalities
that resemble COPD and to integrate multiple readouts in order
to study their inter-relationship. Tissue damage was established
in the PCLS with either elastase or H2O2. We show that ex
vivo elastase, but not H2O2, treatment leads to disruption of
the parenchymal compartment and to enhanced MCh-induced
airway narrowing. Elastase-induced damage was reflected by an
increased Lmi and a disorganization of elastin and collagen fibers.
The structural damage caused by elastase was associated with a
specific decrease in both alveolar Type I and II markers (Aqp5,
Rage, and Sftpc) mRNA expression. H2O2 treatment decreased
gene expression levels of alveolar Type I cells (Rage, Con43,
and T1α) only. As COPD is characterized by both alveolar Type
I and II injury, this result indicates that in the PCLS, elastase
treatment better reproduces tissue damage seen in COPD than
H2O2 treatment.
We observed a clear relationship between lung structure and
airway function. This was demonstrated by the finding that
elastase treatment enhanced MCh-induced airway narrowing as
reflected by an increased pEC50 and Emax values as compared
to control slices. However, a limitation of the PCLS model when
studying lung structure and airway biomechanics is the lack of
pre-strain or cyclic stretching due to tidal breathing. The relative
distribution of forces within the lung has been proposed as a
main player in tissue destruction, and hence is a key contributor
to disease development (Kononov et al., 2001; Suki and Bates,
2011; Yi et al., 2016). In vivo pre-strain and cyclic stretching
are likely able to enhance tissue degradation and are therefore
likely to influence lung tissue biomechanics. This should be
taken into consideration when interpreting the findings of the
presented ex vivo PCLS model. The enhanced airway narrowing
observed in our model is unlikely due to a direct effect of elastase
on smooth muscle α-actin or the M3 receptor, as elastase did
not increase their gene expression levels (data not shown). In
addition, an increased pEC50 value correlated with an increased
Lmi. Furthermore, elastase treatment impaired chloroquine-
induced airway re-opening. Interestingly, it has been shown
that in untreated mouse PCLS, chloroquine, but not the
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FIGURE 3 | Elastase and H2O2 treatment alter mRNA expression levels
of alveolar makers. PCLS were exposed to (A) elastase (2.5 µg/ml, n = 9) or
(B) H2O2 (200 µM, n = 14) for 16 h. After stimulation, slices were washed
twice with medium and incubated for 24 h in medium. The statistical
significance of differences between means was determined on log
transformed data by Student’s t-test followed by a Bonferroni correction. Data
represent mean ± SEM, *p < 0.05 compared to basal control.
β2-agonist salbutamol, is able tomaintain efficacy with increasing
contraction (Donovan et al., 2014). Therefore, whereas β2-
agonists are sensitive to functional antagonism (Lemoine et al.,
1992), this is not the case for chloroquine. This indicates that
the impaired chloroquine-induced relaxation following elastase
treatment is more likely explained by as loss of elastic recoil
due to the absence of functional elastin fibers than by functional
antagonism. The complete airway re-opening with choloroquine
in H2O2 treated slices supports this. A previous study by
Khan et al. demonstrated that ex vivo elastase treatment of
mouse lung slices enhanced the velocity of acetylcholine-induced
contraction while the velocity of relaxation was significantly
suppressed (Khan et al., 2007). In their study, airway narrowing
studies using acetylcholine (ACh) were performed directly after
16 h elastase incubation period. The finding by Khan et al.
that elastase enhances contraction velocity is similar to our
observation that elastase enhances airway narrowing after 16
h incubation and additional 24 h washout period. Although
unquantified, Khan et al. observed rupture of the parenchymal
FIGURE 4 | Elastase, but not H2O2 treatment enhances MCh-induced
airway narrowing. PCLS were exposed to elastase (2.5 µg/ml, n = 10) or
H2O2 (200 µM, n = 10) for 16 h. After stimulation, slices were washed twice
with medium and incubated for 24 h in medium. Following incubation,
MCh-induced airway narrowing was assessed. Lung slice images were
captured in time-lapse (1 frame per 2 s) using an inverted phase contrast
microscope (Eclipse, TS100; Nikon). Airway luminal area was quantified using
image acquisition software (NIS-elements; Nikon), and expressed as percent
basal. (A) MCh-induced airway narrowing following elastase treatment.
Elastase treatment increased pEC50 values significantly (p < 0.05, compared
to basal control). (B) MCh-induced airway narrowing following H2O2 treament.
The statistical significance of differences between means was determined on
log transformed data by one-way ANOVA followed by Bonferonni testing. Data
represent mean ± SEM.
tethering to the airway at the peak of contraction following
elastase treatment. These results fit with our data showing
that increased Lmi correlates with increased pEC50 values, and
implies that structural damage is the cause of enhanced airway
narrowing at both the 16 and 40 h time point. Furthermore, in
another study Khan et al. demonstrated that 16 h treatment of
PCLS with collagenase increased velocity of ACh-induced airway
contraction to a similar extent as elastase, whereas relaxation
velocities were affected to a lesser extent (Khan et al., 2010).
Together, the findings in the studies by Khan et al. and the present
study indicate that parenchymal damage indeed enhances airway
narrowing, and that PCLS are a suitable model to study this
interaction.
In contrast to elastase, H2O2 did not alter Lmi, the pEC50
value or chloroquine-induced airway opening. Collectively, the
above-mentioned results show that elastase, and to a lesser
extent H2O2, treatment of PCLS induces tissue damage similar
to hallmarks of COPD. In addition, these results indicate that
parenchymal disruption is linked to an increased sensitivity of
the airways to MCh-induced contraction, whereas the maximal
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FIGURE 5 | An increased pEC50 value correlates with an increased
Lmi. (A) Lmi (µm) and pEC50 values for all conditions were combined. It was
found that an increased pEC50 value correlates with an increased Lmi (R2 =
0.2838, p < 0.05). (B) Emax values did not correlate with Lmi.
contraction is affected by other processes than parenchymal
disruption alone. The observation that H2O2-treatment did
not alter the parenchymal ECM structure or airway narrowing
confirms our hypothesis that structural disruption of the
parenchyma is necessary for altering airway biomechanics. In
addition, these results suggest that alveolar Type I cell damage
is not immediately involved in altering biomechanics of the
airways as H2O2 lowered expression levels of alveolar Type
I markers without affecting airway narrowing. This indicates
that damage to the matrix and the parenchyma are primarily
responsible. This finding may have implications for COPD,
as the amount of parenchymal tissue disruption is associated
with the severity of COPD (Deslee et al., 2009; Bidan et al.,
2015).
The differential effect of elastase and H2O2 treatment on
the parenchyma and thus airway narrowing might be explained
by how these compounds exert their actions. Elastase directly
digests elastin whereas H2O2 exerts its effects via intracellular
signaling pathways and oxidative modification of structural
proteins and lipids. It is possible that longer H2O2 stimulation
FIGURE 6 | Elastase, but not H2O2 treatment impairs
chloroquine-induced airway opening. PCLS were exposed to elastase (2.5
µg/ml, n = 8) or H2O2 (200 µM, n = 8) for 16 h. After stimulation, slices were
washed twice with medium and incubated for 24 h in medium. Following
incubation, airway narrowing was induced by an increasing dose of MCh.
Subsequently, airway relaxation was induced with chloroquine. Elastase, but
not H2O2 treatment, impaired chloroquine-induced relaxation of contracted
airways. The statistical significance of differences between means was
determined on log transformed data by Student’s t-test. Data represent mean
± SEM, *p < 0.05 compared to basal control.
could have produced structural effects, explaining the small
effect of oxidative stress on the Lmi. In our model, we applied
the stimulation for 16 h and a subsequent wash-out for 24 h
before performing the experiments. The wash-out of 24 h was
chosen in order to have a therapeutic time-window for future
applications of the model as a tool for efficacy monitoring of
experimental treatments. A limitation to our model is the period
the slices are viable. In previous experiments (data not shown)
we demonstrated that airway contractility in PCLS is optimal
between 16 and 52 h after slicing. For this reason, and because
we wished to maintain the wash-out period of 24 h, we did
not attempt to stimulate the PCLS with H2O2 for a longer time
period.
In addition to having differential effects on the parenchyma,
H2O2 and elastase also affected gene expression levels of alveolar
Type I and II markers differentially. Type I cells maintain
the alveolar structure and gas diffusion toward the alveolar
capillaries. Type II cells are the main source of surfactant
proteins, in addition to being the progenitor cells of Type
I cells. Both cell types are crucial for maintaining alveolar
tissue integrity, and the loss of these cells has a direct effect
on the whole parenchyma (Morissette et al., 2009). COPD is
characterized by a loss of alveolar epithelial type I and II cells and
hence alveolar structure integrity (Barnes, 2016). To investigate
the alveolar epithelial repair marker expression after elastase or
H2O2 treatment, several markers were chosen: T1α and Aqp5
(specific for alveolar Type I cells), Con43 and Rage (both alveolar
Type I cell associated), and Sftpc (specific for alveolar Type II
cells; McElroy and Kasper, 2004; Smirnova et al., 2016). Some of
these markers such as Aqp5 and Sftpc are decreased in COPD,
and this decrease is correlated with a lower lung function (Wang
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et al., 2007; Zhao et al., 2014). Following injury of alveolar
epithelial cells, the level of expression of alveolar markers may
change because of an altered regulation or because of the death of
cells expressing the marker. Although both treatments caused a
decrease in themRNA expression levels of alveolar type I markers
(Rage, Con43, T1α), only elastase treatment reduced the alveolar
Type II marker Sftpc. Alveolar Type II cells are secretory cells,
which release components of surfactant and ECM (Fehrenbach,
2001). In addition, they also release the extracellular antioxidants
Gpx3 and Sod3 (Folz et al., 1997; Burk et al., 2011; Yamada
et al., 2012). H2O2 may not alter Sftpc gene expression levels
because of the antioxidant properties of the alveolar Type II
cells, thereby explaining the different effect of elastase and H2O2
on alveolar maker expression levels. A limitation of this study
is that we did not assess PCLS reactivity directly following 16
h of treatment. Hence, we cannot exclude the possibility that
H2O2 had an effect on gene expression levels at this earlier time
point that was lost following 24 h incubation. However, as we
aim to use this model for monitoring experimental treatments
in the future we are interested in creating a model with stable
parenchymal disruption. The effect of elastase on expression
levels of alveolar Type I and II markers may be explained via
several mechanisms. First, elastase-induced elastin fragments are
known chemokines for macrophages in an adult murine model
of emphysema, and elastin fragments can impair alveologenesis
(Houghton et al., 2006; Masood et al., 2015). Second, mechanical
stimuli are well-known to affect proliferation and differentiation
of stem cells (Shah et al., 2014). As elastase disrupts the
parenchyma, it reorganizes the distribution of mechanical forces
within the tissue and may therefore affect the differentiation
of alveolar Type II cells. Together, these mechanisms could
explain how elastase is capable of affecting alveolar marker
expression levels. Collectively, the above-mentioned results
indicate that elastase-treated PCLS serve as a better model
to study the specific relationship between parenchymal
disruption and airway narrowing than H2O2-treated
PCLS.
COPD is a progressive disease, and currently no treatment
is capable of stopping or reversing the progression of lung
decline. Novel therapeutic targets are clearly needed, and the
parenchyma is a good candidate. Recently, there has been
increasing recognition of the potential importance of the
parenchymal compartment and its role in lung tissue mechanics
in many lung diseases, including COPD (Suki and Bates, 2011;
Bidan et al., 2015). In COPD, the parenchyma and ECM are
altered (Eurlings et al., 2014; Bidan et al., 2015). The most
abundant changes in the ECM are reductions in the expression
or functional organization of elastin fiber, leading to a loss of
elastic recoil. Alterations in elastin expression are already present
in mild to moderate COPD, and seen in both airways and
alveoli of COPD patients (Black et al., 2008). Furthermore, this
reduction in elastin expression seems to be similar in mild to
moderate and severe COPD (Eurlings et al., 2014). Interestingly,
alveolar wall elastin fiber structure is altered in patients with
severe COPD. Compared to healthy subjects, elastin fibers from
COPD patients are significantly less densely packed, unraveled
and loose (Deslee et al., 2009). This indicates that, even though
elastin expression is similar in both mild to moderate and
severe COPD, the disruption of the structural organization of
elastin might contribute to the continuous decline of elastic
recoil observed in small airways and parenchyma of patients
with COPD (Bidan et al., 2015). The same appears to be the
case for collagen in COPD. Studies about the total expression
levels of collagen in COPD are inconsistent, but it has been
observed that collagen fibers are more disorganized in severe
COPD as compared tomild tomoderate COPD (Tjin et al., 2014).
Furthermore, recent studies demonstrate that expression of genes
associated with elastogenesis is altered in COPD (Brandsma
et al., 2015, 2016). Among the most upregulated genes were
fibulin-5 (FBLN5), elastin (ELN), latent transforming growth
factor β binding protein 2 (LTBP2), and microfibrillar associated
protein 4 (MFAP4), which are all implicated in elastogenesis.
In addition to elevated gene expression levels of FBLN5
this study demonstrated that cleaved, possibly non-functional
FBLN5 protein was present in COPD lung tissue, indicating
an impaired repair response. Targeting these elastogenesis
pathways in COPD may therefore represent a novel therapeutic
target.
Disorganization of elastin and a changed organization of
collagen fibers were also observed in our PCLS model following
treatment with elastase, demonstrating that elastase treatment
mimics the damage seen in COPD lung tissue. Under basal
conditions, both elastin and collagen fibers were present.
Following elastase treatment, the elastin fibers were lost and
the collagen fibers became more stretched. The importance of
ECM fiber structure is demonstrated by the finding that tissue
strips from elastase-treated mice failed at ∼50% less stress than
control animals, even though the treated animals had a 50%
increase in total collagen content of the lung (Ito et al., 2005).
These results agree with our finding that collagen fibers become
more stretched following elastase treatment; if collagen is
already stretched maximally, it will break at a lower deformation
compared to control. Moreover, due to structural remodeling,
the yield stress (breaking point) of collagen is lower in the
emphysematous lung (Suki and Bates, 2008). A lower yield stress
of collagen also means a lower resistance to airway contraction,
explaining why structural remodeling of collagen can lead to
an enhanced airway narrowing, even though total collagen
expression levels are increased and Lmi is unchanged. Taken
together, these reported findings show that the ECM in the airway
and parenchymal compartments of COPD patients is altered
as compared to non-COPD controls. One of the most evident
alterations is the changed expression level and disorganization
of elastin and collagen fibers. In our PCLS model, elastase
treatment increased the Lmi, disrupted the fiber organization
of elastin and collagen, and enhanced methacholine-induced
airway narrowing as reflected by an increased pEC50 value.
Importantly, increased Lmi values correlated with increased
pEC50 values. Furthermore, elastase treatment impaired
chloroquine-induced airway re-opening. Taken together,
the above-mentioned findings stress the importance of the
contribution of the parenchymal ECM structure to airway
narrowing. It is likely that the enhanced bronchoconstriction
in COPD is at least partly caused by the parenchymal tissue
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damage. This role of the parenchymal compartment in airway
narrowing is especially interesting in mild or moderate COPD,
as changes in the parenchymal compartment are not very
profound yet in stage, and possibly still reversible. Therefore, the
parenchyma represents a promising target in the treatment of
COPD.
In summary, these results demonstrate that PCLS can be
used to model structural defects in COPD in a comprehensive
manner. To our knowledge, this is the first study integrating
multiple read-out parameters such as the parenchyma, epithelial
repair marker expression and airway function in one model.
Using this model, we show that structural disruption of the
parenchymal compartment leads to altered biomechanics of
the airways, enhancing airway contraction. This finding may
have implications for COPD, as the amount of parenchymal
tissue disruption is associated with the severity of the disease.
Therefore, we suggest that the parenchymal tissue damage
observed in COPD contributes to lung function decline by
disrupting airway biomechanics. Targeting the parenchymal
compartment may therefore be a promising therapeutic target in
the treatment of COPD.
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